ATE267263T1 - Eukaryotische genexpressionskassette und deren verwendungen - Google Patents

Eukaryotische genexpressionskassette und deren verwendungen

Info

Publication number
ATE267263T1
ATE267263T1 AT98900570T AT98900570T ATE267263T1 AT E267263 T1 ATE267263 T1 AT E267263T1 AT 98900570 T AT98900570 T AT 98900570T AT 98900570 T AT98900570 T AT 98900570T AT E267263 T1 ATE267263 T1 AT E267263T1
Authority
AT
Austria
Prior art keywords
expression cassette
gene expression
eukaryotic gene
herpes simplex
simplex virus
Prior art date
Application number
AT98900570T
Other languages
English (en)
Inventor
Robert Coffin
David Latchman
Original Assignee
Biovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovex Ltd filed Critical Biovex Ltd
Application granted granted Critical
Publication of ATE267263T1 publication Critical patent/ATE267263T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98900570T 1997-01-10 1998-01-12 Eukaryotische genexpressionskassette und deren verwendungen ATE267263T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700411.3A GB9700411D0 (en) 1997-01-10 1997-01-10 Eukaryotic gene expression cassette and uses thereof
PCT/GB1998/000074 WO1998030707A2 (en) 1997-01-10 1998-01-12 Eukaryotic gene expression cassette and uses thereof

Publications (1)

Publication Number Publication Date
ATE267263T1 true ATE267263T1 (de) 2004-06-15

Family

ID=10805768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900570T ATE267263T1 (de) 1997-01-10 1998-01-12 Eukaryotische genexpressionskassette und deren verwendungen

Country Status (15)

Country Link
EP (2) EP1441033A3 (de)
JP (1) JP2001508294A (de)
KR (1) KR100507399B1 (de)
CN (1) CN1231589C (de)
AT (1) ATE267263T1 (de)
AU (1) AU749064B2 (de)
BR (1) BR9806866A (de)
CA (1) CA2278326A1 (de)
DE (1) DE69824027T2 (de)
DK (1) DK1021553T3 (de)
ES (1) ES2221980T3 (de)
GB (1) GB9700411D0 (de)
IL (2) IL130876A0 (de)
PT (1) PT1021553E (de)
WO (1) WO1998030707A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801930D0 (en) 1998-01-29 1998-03-25 Univ London Mutant herpes simplex viruses and uses thereof
GB9807865D0 (en) * 1998-04-09 1998-06-10 Univ London Herpes simplex virus latency associated transcript polypeptides
US6713067B2 (en) 1998-07-31 2004-03-30 Biovex Limited Herpes viruses for immune modulation
JP2002523024A (ja) * 1998-07-31 2002-07-30 ケンブリッジ ユニバーシティ テクニカル サービシズ リミティド ヘルペスウイルスの潜伏活性調節配列及び遺伝子運搬のための潜伏不活性ヘルペスウイルス
GB9930418D0 (en) 1999-12-22 2000-02-16 Neurovex Ltd Replication incompetent herpes virus vectors
US7063851B2 (en) 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
CZ2003798A3 (cs) 2000-09-21 2003-08-13 Dsm N. V. Polypeptid s aktivitou xylanázy, sekvence nukleové kyseliny kódující polypeptid, způsob přípravy a použití polypeptidu
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
TWI328612B (en) 2002-07-25 2010-08-11 Dsm Ip Assets Bv Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12
CN1701120A (zh) * 2002-09-27 2005-11-23 磨粉机械研究有限公司 用于基因表达的核酸构建体
GB0317511D0 (en) 2003-07-25 2003-08-27 Biovex Ltd Viral vectors
WO2005080581A2 (en) * 2004-02-17 2005-09-01 University Of Florida Research Foundation, Inc. Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression
US9593347B2 (en) 2010-04-16 2017-03-14 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
RU2020105656A (ru) * 2013-07-17 2021-01-27 Юниверсити Оф Питтсбург- Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Нетоксичные векторы на основе впг для применений в эффективной доставке генов и комплементирующие клетки для их продуцирования
KR102490462B1 (ko) 2013-10-28 2023-01-19 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 종양분해성 hsv 벡터
WO2017118866A1 (en) 2016-01-08 2017-07-13 Replimune Limited Engineered virus
ES2919953T3 (es) 2016-01-27 2022-07-29 Oncorus Inc Vectores víricos oncolíticos y usos de los mismos
GB201700350D0 (en) * 2017-01-09 2017-02-22 Replimune Ltd Altered virus
RU2771110C2 (ru) 2017-07-26 2022-04-26 Онкорус, Инк. Онколитические вирусные векторы и их применение
AU2020284255A1 (en) * 2019-05-30 2022-01-06 Solid Biosciences Inc. Recombinant herpesvirales vector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
DE69328514T2 (de) * 1992-03-13 2001-01-11 Monsanto Co., St. Louis Herstellung rekombinanter Proteine unter Verwendung von Herpes-Virus-Promotoren und VP16-Transaktivatoren

Also Published As

Publication number Publication date
DE69824027T2 (de) 2004-10-28
IL130876A0 (en) 2001-01-28
PT1021553E (pt) 2004-09-30
AU5566998A (en) 1998-08-03
WO1998030707A3 (en) 1998-09-11
AU749064B2 (en) 2002-06-20
CN1250480A (zh) 2000-04-12
DK1021553T3 (da) 2004-09-27
BR9806866A (pt) 2000-04-18
DE69824027D1 (de) 2004-06-24
KR100507399B1 (ko) 2005-08-10
EP1021553A2 (de) 2000-07-26
JP2001508294A (ja) 2001-06-26
EP1441033A3 (de) 2004-12-01
GB9700411D0 (en) 1997-02-26
IL130876A (en) 2006-08-20
CA2278326A1 (en) 1998-07-16
EP1021553B1 (de) 2004-05-19
EP1441033A2 (de) 2004-07-28
CN1231589C (zh) 2005-12-14
WO1998030707A2 (en) 1998-07-16
KR20000070037A (ko) 2000-11-25
ES2221980T3 (es) 2005-01-16

Similar Documents

Publication Publication Date Title
DE69824027D1 (de) Eukaryotische genexpressionskassette und deren verwendungen
NO303831B1 (no) Isolert DNA-sekvens, vektor, vertscelle, polypeptid og anvendelse in vitro av polypeptidet ved en fremgangsmÕte for transfeksjon av hematopoeseceller med eksogen DNA
ATE79649T1 (de) Herpes simplex-virus als vektor.
MX9800719A (es) Proteinas de transporte y sus usos.
ES2150894T1 (es) Vector de baculovirus modificado por proteinas de envoltura para terapia genica.
ATE321869T1 (de) Fusionproteine für intra- und interzelluläre transport und deren verwendungen
DE69634752D1 (de) Adenovirale vektoren beinhaltend ein prostata spezifisches antigen (psa) "response element"
AU3675095A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
ES2164260T3 (es) Vectores virales para la terapia genica.
WO1998027204A3 (en) AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors
ZA957797B (en) Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell
IE842210L (en) Vaccine
AU1851895A (en) Host-vector system for use in gene therapy
DE3853474D1 (de) Vektor zur integrationsstellenunabhängigen genexpression in säugetier-wirtszellen.
ES2196014T3 (es) Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.
AU1278695A (en) Homologous recombination antibody expression system for murine cells
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
NO963627L (no) Gener og genetiske elementer assosiert med kontroll av neoplastisk transformasjon i pattedyrceller
WO2002014527A3 (en) Gp64-null baculoviruses pseudotyped with heterologous envelope proteins
AU582288B2 (en) Vector and method for achieving high level expression in eukaryotic cells
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
EP0774513A4 (de) REKOMBINANTES HERPESVIRUS UNTER DER VERWENDUNG DES gB GENPROMOTERS
AU2233297A (en) Promoter
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1021553

Country of ref document: EP

REN Ceased due to non-payment of the annual fee